Literature DB >> 8133053

IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11.

J A Elias1, T Zheng, N L Whiting, T K Trow, W W Merrill, R Zitnik, P Ray, E M Alderman.   

Abstract

IL-11 and IL-6 are fibroblast-derived cytokines with overlapping biologic properties. To determine whether IL-11 and IL-6 are similarly regulated, we characterized the effects of rIL-1 and TGF-beta (beta 1 and beta 2) on human lung fibroblast IL-11 production and compared this regulation with that of IL-6. Unstimulated fibroblasts did not produce significant amounts of IL-11, whereas rIL-1 alpha and TGF-beta were dose-dependent stimulators of IL-11 protein production, mRNA accumulation, and gene transcription. rIL-1 alpha and TGF-beta also interacted in a synergistic fashion to further increase IL-11 protein production and mRNA accumulation. The effects of rIL-1 and TGF-beta individually were not altered by the cyclic nucleotide-dependent protein kinase inhibitor HA1004, protein kinase C (PKC) inhibition with staurosporine, or chronic phorbol ester preincubation, or the calmodulin antagonists W7 and TFP. The effects of rIL-1 alpha and TGF-beta in combination were also unaltered by HA1004, staurosporine, and chronic phorbol ester exposure. A23187, however, did induce IL-11 mRNA accumulation and W7 and TFP did reverse the synergistic stimulation caused by rIL-1 and TGF-beta in combination. In contrast with the regulation of IL-11, TGF-beta did not effectively stimulate IL-6 mRNA accumulation, rIL-1 alpha was a more potent stimulator of IL-6 than IL-11 production, and rIL-1-induced IL-6 mRNA accumulation was augmented by W7 and TFP. These studies demonstrate that: 1) rIL-1, TGF-beta, and agents that increase intracellular calcium stimulate lung fibroblast IL-11; 2) the IL-11 stimulatory effects of rIL-1 and TGF-beta are, at least partially, transcriptionally mediated and are the result of signal transduction pathways that are largely PKC, cyclic nucleotide, and calmodulin independent; and 3) rIL-1 and TGF-beta interact in a synergistic fashion to further increase fibroblast IL-11 production and that this synergy is mediated by a largely PKC- and cyclic nucleotide-independent and calmodulin-dependent activation pathway. Importantly, they also demonstrate that rIL-1 and TGF-beta stimulate lung fibroblast IL-6 and IL-11 production via distinct and differentially regulatable activation pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8133053

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Differential inhibitory effects of indomethacin, dexamethasone, and interferon-gamma (IFN-gamma) on IL-11 production by rheumatoid synovial cells.

Authors:  H Taki; E Sugiyama; T Mino; A Kuroda; M Kobayashi
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells.

Authors:  Hatem A Elshabrawy; Michael V Volin; Abdul B Essani; Zhenlong Chen; Iain B McInnes; Katrien Van Raemdonck; Karol Palasiewicz; Shiva Arami; Mark Gonzalez; Hossam M Ashour; Seung-Jae Kim; Guofei Zhou; David A Fox; Shiva Shahrara
Journal:  Angiogenesis       Date:  2018-01-11       Impact factor: 9.596

3.  Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction.

Authors:  W Tang; G P Geba; T Zheng; P Ray; R J Homer; C Kuhn; R A Flavell; J A Elias
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.

Authors:  T Zheng; Z Zhu; Z Wang; R J Homer; B Ma; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.

Authors:  P Ray; W Tang; P Wang; R Homer; C Kuhn; R A Flavell; J A Elias
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

6.  Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production.

Authors:  Chun Geun Lee; Dominik Hartl; Hiroshi Matsuura; Felicity M Dunlop; Pierre D Scotney; Louis J Fabri; Andrew D Nash; Ning-Yuan Chen; Chu-Yan Tang; Qingsheng Chen; Robert J Homer; Manuel Baca; Jack A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-10       Impact factor: 6.914

7.  Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway.

Authors:  Li Ren; Xia Wang; Zuoliang Dong; Jun Liu; Shiwu Zhang
Journal:  Med Oncol       Date:  2013-06-28       Impact factor: 3.064

8.  Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation.

Authors:  Yuben P Moodley; Amelia K Scaffidi; Neil L Misso; Carmel Keerthisingam; Robin J McAnulty; Geoff J Laurent; Steven E Mutsaers; Philip J Thompson; Darryl A Knight
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

9.  A comparison of the effects of signal transduction inhibitors on oxidative burst and degranulation in IL-I beta stimulated bovine neutrophils.

Authors:  P W Yu; C J Czuprynski
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

10.  Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation.

Authors:  Z Zhu; W Tang; A Ray; Y Wu; O Einarsson; M L Landry; J Gwaltney; J A Elias
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.